Nanomedicine Vol. 15 No. 10 | Editorial

Dendritic cell-targeted theranostic nanomedicine: advanced cancer nanotechnology for diagnosis and therapy


The development of advanced and efficient tumor immunotherapy is one of the key functional areas in current medicine as a cutting-edge therapeutic approach. Dendritic cells (DCs) are highly effective antigen-presenting cells that display a key role in trapping, processing and presenting antigens to initiate adaptive immunity. These cells play an important role in the development of immune-based nanodiagnostics and nanotherapeutics. A wide range of DC-targeted immunotherapies based on nanotechnology have evolved as safer medications for a variety of diseases and now it has been demonstrated in ongoing clinical trials. The aim of this editorial is to discuss the DC-targeted nano-immunotherapy and its theranostic applications.

View the full article Go to Journal Content page